• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

我们是否需要心肌细胞坏死的额外标志物:心脏脂肪酸结合蛋白的潜在价值。

Do we need additional markers of myocyte necrosis: the potential value of heart fatty-acid-binding protein.

作者信息

Alhadi H A, Fox K A A

机构信息

Cardiovascular Research Unit, Centre for Cardiovascular Science, University of Edinburgh, Royal Infirmary of Edinburgh, Edinburgh, UK.

出版信息

QJM. 2004 Apr;97(4):187-98. doi: 10.1093/qjmed/hch037.

DOI:10.1093/qjmed/hch037
PMID:15028848
Abstract

Heart fatty-acid-binding protein (FABP) is a small cytosolic protein that is abundant in the heart and has low concentrations in the blood and in tissues outside the heart. It appears in the blood as early as 1.5 h after onset of symptoms of infarction, peaks around 6 h and returns to baseline values in 24 h. These features of H-FABP make it an excellent potential candidate for the detection of acute myocardial infarction (AMI). We review the strengths and weaknesses of H-FABP as a clinically applicable marker of myocyte necrosis in the context of acute coronary syndromes.

摘要

心脏脂肪酸结合蛋白(FABP)是一种小的胞质蛋白,在心脏中含量丰富,而在血液和心脏以外的组织中浓度较低。它在梗死症状出现后1.5小时最早出现在血液中,约6小时达到峰值,并在24小时内恢复到基线值。H-FABP的这些特性使其成为检测急性心肌梗死(AMI)的极佳潜在候选物。我们在急性冠状动脉综合征的背景下,综述了H-FABP作为心肌细胞坏死临床适用标志物的优缺点。

相似文献

1
Do we need additional markers of myocyte necrosis: the potential value of heart fatty-acid-binding protein.我们是否需要心肌细胞坏死的额外标志物:心脏脂肪酸结合蛋白的潜在价值。
QJM. 2004 Apr;97(4):187-98. doi: 10.1093/qjmed/hch037.
2
[Diagnostic value of heart fatty-acid binding protein in early hospitalized patients with non ST elevation acute coronary syndrome].[心脏脂肪酸结合蛋白在非ST段抬高型急性冠状动脉综合征早期住院患者中的诊断价值]
Kardiologiia. 2003;43(5):4-8.
3
Human heart-type cytoplasmic fatty acid-binding protein (H-FABP) for the diagnosis of acute myocardial infarction. Clinical evaluation of H-FABP in comparison with myoglobin and creatine kinase isoenzyme MB.用于诊断急性心肌梗死的人心脏型细胞质脂肪酸结合蛋白(H-FABP)。H-FABP与肌红蛋白和肌酸激酶同工酶MB的临床评估。
Clin Chem Lab Med. 2000 Mar;38(3):231-8. doi: 10.1515/CCLM.2000.034.
4
The use of human heart-type fatty acid-binding protein as an early diagnostic biochemical marker of myocardial necrosis in patients with acute coronary syndrome, and its comparison with troponin-T and creatine kinase-myocardial band.人心脏型脂肪酸结合蛋白作为急性冠状动脉综合征患者心肌坏死的早期诊断生化标志物的应用及其与肌钙蛋白T和肌酸激酶同工酶的比较。
Heart Vessels. 2006 Sep;21(5):309-14. doi: 10.1007/s00380-006-0908-2. Epub 2006 Sep 29.
5
Release of heart fatty acid-binding protein into plasma after acute myocardial infarction in man.急性心肌梗死后人体血浆中心脏脂肪酸结合蛋白的释放
Mol Cell Biochem. 1992 Oct 21;116(1-2):155-62. doi: 10.1007/BF01270583.
6
Unbound free fatty acids and heart-type fatty acid-binding protein: diagnostic assays and clinical applications.游离脂肪酸与心脏型脂肪酸结合蛋白:诊断检测方法及临床应用
Clin Chem. 2006 Jan;52(1):19-29. doi: 10.1373/clinchem.2005.056143. Epub 2005 Nov 3.
7
Heart-type fatty acid binding protein--a reliable marker of myocardial necrosis in a heterogeneous group of patients with acute coronary syndrome without persistent ST elevation.心脏型脂肪酸结合蛋白——急性非持续性ST段抬高型冠脉综合征异质性患者群体中心肌坏死的可靠标志物。
Kardiol Pol. 2008 Mar;66(3):253-9, discussion 260-1.
8
Direct comparison of the diagnostic value of point-of-care tests detecting heart-type fatty acid binding protein or glycogen phosphorylase isoenzyme BB in patients with acute coronary syndromes with persistent ST-segment elevation.在伴有持续 ST 段抬高的急性冠状动脉综合征患者中,检测心脏型脂肪酸结合蛋白或糖原磷酸化酶同工酶 BB 的即时检测点比较诊断价值的直接比较。
Kardiol Pol. 2011;69(1):1-6.
9
Human heart-type fatty acid-binding protein as an early diagnostic and prognostic marker in acute coronary syndrome.人心脏型脂肪酸结合蛋白作为急性冠脉综合征的早期诊断和预后标志物
Cardiology. 2003;99(2):96-104. doi: 10.1159/000069726.
10
[The significance of a 4,183 Da peptide of dermcidin protein in the early diagnosis and differential diagnosis of acute coronary syndrome].[皮肤杀菌蛋白4183道尔顿肽段在急性冠脉综合征早期诊断及鉴别诊断中的意义]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2015 Dec;27(12):970-4. doi: 10.3760/cma.j.issn.2095-4352.2015.12.006.

引用本文的文献

1
Prognostic value of a combination of cardiac biomarkers and risk indices for major adverse cardiovascular events following non-cardiac surgery in geriatric patients: a prospective cohort study.心脏生物标志物与风险指数联合对老年患者非心脏手术后主要不良心血管事件的预后价值:一项前瞻性队列研究
Sci Rep. 2025 Apr 17;15(1):13336. doi: 10.1038/s41598-025-95987-8.
2
Utilizing Nanomaterials in Microfluidic Devices for Disease Detection and Treatment.在微流控设备中利用纳米材料进行疾病检测与治疗。
Nanomaterials (Basel). 2025 Mar 12;15(6):434. doi: 10.3390/nano15060434.
3
Insight of Intestinal Fatty Acid Binding Protein as a Potential Biomarker in the Biology of Epithelial Damage of Gastrointestinal Membrane.
肠道脂肪酸结合蛋白作为胃肠膜上皮损伤生物学中潜在生物标志物的见解
Curr Protein Pept Sci. 2025;26(5):321-333. doi: 10.2174/0113892037311290240930054913.
4
Association of H-FABP with cardiovascular events: A systematic review.H-FABP与心血管事件的关联:一项系统综述。
J Cardiovasc Thorac Res. 2024;16(2):77-87. doi: 10.34172/jcvtr.33039. Epub 2024 Jun 25.
5
V-A ECMO for neonatal coxsackievirus B fulminant myocarditis: a case report and literature review.新生儿B组柯萨奇病毒暴发性心肌炎的静脉-动脉体外膜肺氧合治疗:一例报告及文献综述
Front Cardiovasc Med. 2024 May 21;11:1364289. doi: 10.3389/fcvm.2024.1364289. eCollection 2024.
6
The Impact of Normobaric Hypoxia and Intermittent Hypoxic Training on Cardiac Biomarkers in Endurance Athletes: A Pilot Study.常压低氧及间歇性低氧训练对耐力运动员心功能标志物的影响:一项初步研究。
Int J Mol Sci. 2024 Apr 23;25(9):4584. doi: 10.3390/ijms25094584.
7
Aptamers Targeting Cardiac Biomarkers as an Analytical Tool for the Diagnostics of Cardiovascular Diseases: A Review.靶向心脏生物标志物的适体作为心血管疾病诊断的分析工具:综述
Biomedicines. 2022 May 6;10(5):1085. doi: 10.3390/biomedicines10051085.
8
Comparison of Serum Heart-Type Fatty Acid Binding Protein Levels in Stable Chronic Obstructive Pulmonary Disease and Healthy Subjects.稳定期慢性阻塞性肺疾病患者与健康受试者血清心脏型脂肪酸结合蛋白水平的比较
Tanaffos. 2020 Jul;19(3):208-215.
9
Diagnostic and Prognostic Biomarkers for Myocardial Infarction.心肌梗死的诊断和预后生物标志物
Front Cardiovasc Med. 2021 Feb 3;7:617277. doi: 10.3389/fcvm.2020.617277. eCollection 2020.
10
Circulating Cardiac Biomarkers in Diabetes Mellitus: A New Dawn for Risk Stratification-A Narrative Review.糖尿病中的循环心脏生物标志物:风险分层的新曙光——一篇叙述性综述
Diabetes Ther. 2020 Jun;11(6):1271-1291. doi: 10.1007/s13300-020-00835-9. Epub 2020 May 19.